Development of molnupiravir and peramivir loaded liposome formulations for combined antiviral therapy
{{output}}
The pandemic caused by the SARS-CoV-2 virus has led scientists to intensify research on antiviral drugs and vaccines. As a result of these studies, it was observed that molnupiravir (MLP) and peramivir (PRV) could be used against pandemic. MLP affects SARS-CoV... ...
